Delivery Order SPE2DB22D3501-SPE2DB25FXL77
Award Date 9/22/25
Potential Completion Date 10/14/25
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (20 mg-8.19 mg tablets, 60-count packages) with a ceiling value of $10,173.33. This competitively awarded, non-set-aside contract is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,406.92 to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (quantity 20) on October 20, 2025, with completion expected by November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,173.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (trifluridine/tipiracil) 20 mg-8.19 mg tablets in quantities of 60 units. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 30, 2025, with performance at the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,520.28 to AmerisourceBergen Drug Corp for the supply of LONSURF (20 mg-8.19 mg tablets) in quantities of 40 units. This competitive award, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, 20-count) on October 22, 2025, with a ceiling value of $6,813.86 and an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $6.76K to AmerisourceBergen Drug Corp for the supply of LONSURF 20 mg–8.19 mg tablets (40-count packages). This non-competitive, firm fixed-price delivery order was issued on June 16, 2025, with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LONSURF is a combination chemotherapy medication used in cancer treatment, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $12.7K to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (60-count supply). This non-set-aside, firm fixed-price delivery order was awarded on July 24, 2025, with completion scheduled for August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LONSURF is a prescription oncology medication used in cancer treatment, reflecting the company's role...
- The Defense Logistics Agency awarded a delivery order valued at $10,173.33 to AmerisourceBergen Drug Corp for the supply of Lonsurf (20 mg-8.19 mg tablets, quantity 60) under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $5,078.30 to AmerisourceBergen Drug Corp for the supply of LONSURF (15 mg-6.14 mg tablets, quantity 20) with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. LONSURF is an FDA-approved combination chemotherapy medication used in oncology treatment,...